Biotech specialises in autoimmune disorder drugs.
Earlier decision to reject drug reversed.
Otezla cheap and convenient, but less effective than rivals, says NICE.
Sales of dermatology drug are already mounting.
GW goes to FDA with cannabinoid epilepsy drug.
Analysts left guessing from snippet of early phase data.
Sanofi criticised following failure of Medivation bid.
Sanofi has competition in its bid to acquire cancer specialist